Arylazanylpyrazolone derivatives as inhibitors of mutant superoxide dismutase 1 dependent protein aggregation for the treatment of amyotrophic lateral sclerosis.
about
Arylazanylpyrazolone derivatives as inhibitors of mutant superoxide dismutase 1 dependent protein aggregation for the treatment of amyotrophic lateral sclerosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Arylazanylpyrazolone derivativ ...... amyotrophic lateral sclerosis.
@ast
Arylazanylpyrazolone derivativ ...... amyotrophic lateral sclerosis.
@en
type
label
Arylazanylpyrazolone derivativ ...... amyotrophic lateral sclerosis.
@ast
Arylazanylpyrazolone derivativ ...... amyotrophic lateral sclerosis.
@en
prefLabel
Arylazanylpyrazolone derivativ ...... amyotrophic lateral sclerosis.
@ast
Arylazanylpyrazolone derivativ ...... amyotrophic lateral sclerosis.
@en
P2093
P2860
P356
P1476
Arylazanylpyrazolone derivativ ...... amyotrophic lateral sclerosis
@en
P2093
Cindy Voisine
Donald R Kirsch
Radhia Benmohamed
Richard B Silverman
Richard I Morimoto
P2860
P304
P356
10.1021/JM400079A
P407
P50
P577
2013-03-15T00:00:00Z